ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Specialist

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,623Medicare Part D Prescriptions Filled, Including Refills

Rank: 5 out of 326

$444K Total Retail Price of All Prescriptions

Rank: 45 out of 326

236 Patients Receiving at Least One Drug in Part D
60%Patients 65 Years and Older
83% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Michigan
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

54% of this provider’s 236 patients filled at least one prescription for a schedule three drug, compared to an average of 16%.

Risky Drugs to Seniors

4% of this provider’s 6,646 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$42 was the average price of a prescription from this provider, compared to $104 among peers.

Prescriptions per Patient

45 is the average number of prescriptions (including refills) per patient, compared to an average of 9.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Michigan
HYDROCODONE-ACETAMINOPHEN 933 407 S3 1 1
FUROSEMIDE 429 292 2 7
SIMVASTATIN 417 307 3 2
METOPROLOL SUCCINATE 351 236 4 9
TRIAMTERENE-HCTZ 286 136 5 72
AMLODIPINE BESYLATE 238 168 6 8
METOPROLOL TARTRATE 234 101 7 6
LISINOPRIL 223 153 8 3
ENALAPRIL MALEATE 204 105 9 65
OMEPRAZOLE 202 153 10 5
ATORVASTATIN CALCIUM 192 136 11 10
METFORMIN HCL 188 113 12 16
ISOSORBIDE MONONITRATE ER 182 129 13 19
CLOPIDOGREL 175 124 14 23
LEVOTHYROXINE SODIUM 174 110 15 4
ACETAMINOPHEN-CODEINE 163 116 S3 16 96
CILOSTAZOL 162 151 17 187
POTASSIUM CHLORIDE 162 110 17 21
GLYBURIDE 156 127 R 19 117
RANITIDINE HCL 142 104 20 43
CARISOPRODOL 139 14 R 21 88
NAPROXEN 134 96 22 137
PANTOPRAZOLE SODIUM 126 61 23 66
HYDRALAZINE HCL 121 70 24 48
PROAIR HFA 120 89 25 100
NIFEDIPINE ER 116 82 26 122
PLAVIX 115 84 27 39
IBUPROFEN 104 32 28 62
METOLAZONE 91 52 29 193
VENTOLIN HFA 89 33 30 273
CYMBALTA 88 64 31 61
MELOXICAM 88 77 31 80
CLONIDINE HCL 87 75 33 74
NADOLOL 86 37 34 276
KLOR-CON M20 85 79 35 114
SPIRIVA 85 39 35 129
ATENOLOL 77 53 37 13
LACTULOSE 76 68 38 144
LYRICA 76 35 38 94
INSULIN SYRINGE 71 33 40 128
PRAZOSIN HCL 67 19 41 299
GLIPIZIDE 62 18 42 106
NITROSTAT 62 43 42 71
CYCLOBENZAPRINE HCL 61 38 R 44 95
CARVEDILOL 61 56 44 12
HYDROCHLOROTHIAZIDE 60 34 46 24
MECLIZINE HCL 59 48 47 246
CELEBREX 57 28 48 131
WARFARIN SODIUM 56 26 49 11
PREDNISONE 55 22 50 18
LANTUS 55 11 50 56
SINGULAIR 51 38 52 171
VERAPAMIL ER 50 36 53 257
DILTIAZEM 24HR ER 50 49 53 140
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Nov. 18, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.